1. Home
  2. WRBY vs EVO Comparison

WRBY vs EVO Comparison

Compare WRBY & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRBY
  • EVO
  • Stock Information
  • Founded
  • WRBY 2010
  • EVO 1993
  • Country
  • WRBY United States
  • EVO Germany
  • Employees
  • WRBY N/A
  • EVO N/A
  • Industry
  • WRBY Ophthalmic Goods
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRBY Health Care
  • EVO Health Care
  • Exchange
  • WRBY Nasdaq
  • EVO Nasdaq
  • Market Cap
  • WRBY 2.7B
  • EVO 1.5B
  • IPO Year
  • WRBY 2021
  • EVO 2021
  • Fundamental
  • Price
  • WRBY $23.21
  • EVO $4.12
  • Analyst Decision
  • WRBY Buy
  • EVO Buy
  • Analyst Count
  • WRBY 16
  • EVO 2
  • Target Price
  • WRBY $23.33
  • EVO $5.90
  • AVG Volume (30 Days)
  • WRBY 1.8M
  • EVO 113.5K
  • Earning Date
  • WRBY 08-07-2025
  • EVO 08-13-2025
  • Dividend Yield
  • WRBY N/A
  • EVO N/A
  • EPS Growth
  • WRBY N/A
  • EVO N/A
  • EPS
  • WRBY N/A
  • EVO N/A
  • Revenue
  • WRBY $795,094,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • WRBY $16.13
  • EVO $10.08
  • Revenue Next Year
  • WRBY $13.87
  • EVO $10.99
  • P/E Ratio
  • WRBY N/A
  • EVO N/A
  • Revenue Growth
  • WRBY 13.94
  • EVO 1.50
  • 52 Week Low
  • WRBY $12.46
  • EVO $2.84
  • 52 Week High
  • WRBY $28.68
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • WRBY 61.79
  • EVO 49.74
  • Support Level
  • WRBY $21.13
  • EVO $4.12
  • Resistance Level
  • WRBY $22.72
  • EVO $4.26
  • Average True Range (ATR)
  • WRBY 0.82
  • EVO 0.11
  • MACD
  • WRBY -0.05
  • EVO -0.01
  • Stochastic Oscillator
  • WRBY 98.93
  • EVO 41.03

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: